Meta-analysis of 17 studies (7007 fetuses) with nuchal translucency 3.0–3.4 mm: chromosomal anomalies in 13.1% (trisomy 21 8.0%), pathogenic CNVs 2.5%, single-gene disorders 5.7%; most anomalies potentially detectable by cfDNA.
Meta-analysisn = 7,007 fetuses
Carta et al. Chromosomal and genetic anomalies in fetuses with nuchal translucency between 3.0 and 3.4 mm: A systematic review and meta-analysis